Thyroid Disorders

  • David S. Cooper


Thyroid problems in the elderly are commonly encountered and are challenging to diagnose and treat. In the geriatric population, the prevalence of certain thyroid diseases (e.g., nodules, goiter, hypothyroidism) is high, and some thyroid disorders (e.g., hyperthyroidism) may have subtle or atypical presentations. In older patients with common associated nonthyroidal illnesses, thyroid function tests may be altered, making their interpretation all the more difficult. Finally, therapy may be more complex than in younger patients, due to the presence of underlying chronic illness, especially cardiac disease, and because of altered thyroid hormone metabolism.


Thyroid Hormone Thyroid Nodule Subclinical Hypothyroidism Multinodular Goiter Antithyroid Drug 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Irvine RE. Thyroid disease in old age. In: Brocklehurst JC, ed. Textbook of Geriatric Medicine and Geronotology. New York: Churchill-Livingstone; 1973: 435–458.Google Scholar
  2. 2.
    Tunbridge WMG, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Wickham survey. Clin Endocrinol. 1977; 7: 481–493.CrossRefGoogle Scholar
  3. 3.
    Denham MJ, Wills EJ. A clinico-pathological survey of thyroid glands in old age. Gerontology. 1980; 26: 160–166.PubMedCrossRefGoogle Scholar
  4. 4.
    Gregerman RI, Gaffney GW, Shock NW, et al. Thyroxine turnover in euthyroid man with special reference to changes with age. J Clin Invest. 1962; 41: 2565–2574.CrossRefGoogle Scholar
  5. 5.
    Mokshagundam S, Barzel US. Thyroid disease in the elderly. J Am Geriatr Soc. 1993; 41: 1361–1369.PubMedGoogle Scholar
  6. 6.
    Mariotti S, Barbesino G, Caturegli P, et al. Complex alteration of thyroid function in healthy centenarians. J Clin Endocrinol Metab. 1993; 77: 1130–1134.PubMedCrossRefGoogle Scholar
  7. 7.
    Kabadi UM, Rosman PM. Thyroid hormone indices in adult healthy subjects: no influence of aging. J Am Geriatr Soc. 1988; 36: 312–316.PubMedGoogle Scholar
  8. 8.
    Hershman JM, Pekary AE, Berg L, et al. Serum thyrotropin and thyroid hormone levels in elderly and middle-aged eu-thyroid persons. J Am Geriatr Soc. 1993; 41: 823–828.PubMedGoogle Scholar
  9. 9.
    Parle JV, Franklyn JA, Cross KW, et al. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol. 1991; 34: 77–83.CrossRefGoogle Scholar
  10. 10.
    Lipson A, Nickoloff L, Hsu TH, et al. A study of age-dependent changes in thyroid function tests in adults. J Nucl Med. 1979; 20: 1124–1130.PubMedGoogle Scholar
  11. 11.
    Lazar MA. Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr Rev. 1993; 14: 194–202.Google Scholar
  12. 12.
    Davis PJ, Davis FB, Blas SD, et al. Donor age-dependent decline in response of human RBC Ca++/ATPase activity to thyroid hormone in vitro. J Clin Endocrinol Metab. 1987; 64: 921–925.PubMedCrossRefGoogle Scholar
  13. 13.
    Mooradian AD, Wong NCW. Age-related changes in thyroid hormone action. Eur J Endocrinol. 1994; 131: 451–461.PubMedCrossRefGoogle Scholar
  14. 14.
    Kvetny J. Nuclear T, and T3 binding in mononuclear cells in dependence of age. Horm Metab Res. 1985; 17: 35–38.PubMedCrossRefGoogle Scholar
  15. 15.
    Nicoloff JT, Spencer CA. The use and misuse of the sensitive thyrotropin assays. J Clin Endocrinol Metab. 1990; 71: 553–558.PubMedCrossRefGoogle Scholar
  16. 16.
    Franklyn JA, Black EG, Betteridge J, et al.Comparison of second and third generation methods for measurement of serum thyrotropin in patients with overt hyperthyroidism, patients receiving thyroxine therapy, and those with non-thyroidal illness. J Clin Endocrinol Metab. 1994; 78: 1368–1371.PubMedCrossRefGoogle Scholar
  17. 17.
    Sundbeck G, Jagenburg R, Johansson P-M, Eden S, Lindstedt G. Clinical significance of low serum thyrotropin concentration by chemiluminometric assay in 85-year-old women and men. Arch Intern Med. 1991; 151: 549–556.PubMedCrossRefGoogle Scholar
  18. 18.
    Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994; 331: 1249–1252.PubMedCrossRefGoogle Scholar
  19. 19.
    Ronnov-Jessen V, Kirkegaard C. Hyperthyroidism: a disease of old age? Br Med J. 1973; 1: 41–43.PubMedCrossRefGoogle Scholar
  20. 20.
    Greenwood RM, Daly JG, Himsworth RL. Hyperthyroidism and the impalpable thyroid gland. Clin Endocrinol. 1985; 22: 583–587.CrossRefGoogle Scholar
  21. 21.
    Tibaldi JM, Barzel US, Albin J, et al. Thyrotoxicosis in the very old. Am J Med. 1986; 81: 619–622.PubMedCrossRefGoogle Scholar
  22. 22.
    Davis PJ, Davis FB. Hyperthyroidism in patients over the age of 60 years: clinical features in 85 patients. Medicine. 1974; 53: 161–181.PubMedCrossRefGoogle Scholar
  23. 23.
    Nordyke RA, Gilbert FI, Harada ASM. Graves’ disease. Influence of age on clinical findings. Arch Intern Med. 1988; 184: 626–631.CrossRefGoogle Scholar
  24. 24.
    Cobler JL, Williams ME, Greenland P. Thyrotoxicosis in institutionalized elderly patients with atrial fibrillation. Arch Intern Med. 1984; 144: 1758–1760.PubMedCrossRefGoogle Scholar
  25. 25.
    Woeber KA. Thyrotoxicosis and the heart. N Engl J Med. 1992; 327: 94–98.PubMedCrossRefGoogle Scholar
  26. 26.
    Perros P, Crombie AL, Matthews JNS, et al. Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic. Clin Endocrinol. 1993; 38: 367–372.CrossRefGoogle Scholar
  27. 27.
    Kendler DL, Lippa J, Rootman J. The initial clinical characteristics of Graves’ orbitopathy vary with age and sex. Arch Ophthalmol. 1993; 111: 197–200.PubMedCrossRefGoogle Scholar
  28. 28.
    Caplan RH, Glasser JE, Davis K, et al. Thyroid function tests in elderly hyperthyroid patients. J Am Geriatr Soc. 1978; 26: 116–120.PubMedGoogle Scholar
  29. 29.
    Kawabe T, Komiya I, Endo T, et al. Hyperthyroidism in the elderly. J Am Geriatr Soc. 1979; 27: 152–155.PubMedGoogle Scholar
  30. 30.
    Trzepacz PT, Klein I, Roberts M, et al. Graves’ disease: an analysis of thyroid hormone levels and hyperthyroid signs and symptoms. Am J Med. 1989; 87: 558–561.PubMedCrossRefGoogle Scholar
  31. 31.
    Aizawa T, Ishihara M, Hashizume K, et al. Age-related changes of thyroid function and immunologic abnormalities in patients with hyperthyroidism due to Graves’ disease. J Am Geriatr Soc. 1989; 37: 944–948.PubMedGoogle Scholar
  32. 32.
    Yamada T, Aizawa T, Koizumi Y, et al. Age-related therapeutic response to antithyroid drug in patients with hyperthyroid Graves’ disease. J Am Geriatr Soc. 1994; 42: 513–516.PubMedGoogle Scholar
  33. 33.
    Borst GC, Eil C, Burman KD. Euthyroid hyperthyroxinemia. Ann Intern Med. 1983; 98: 366–378.PubMedGoogle Scholar
  34. 34.
    Figge J, Leinung M, Goodman AD, et al. The clinical evaluation of patients with subclinical hyperthyroidism and free triiodothyronine (free T3) toxicosis. Am J Med. 1994; 96: 229–234.PubMedCrossRefGoogle Scholar
  35. 35.
    Wehmann RE, Gregerman RI, Burns WH, et al. Suppression of thyrotropin in the low-thyroxine state of severe nonthyroidal illness. N Engl J Med. 1985; 312: 546–552.PubMedCrossRefGoogle Scholar
  36. 36.
    Gordon M, Gryfe Cl. Hyperthyroidism with painless subacute thyroiditis in the elderly. JAMA. 1981; 246: 2354–2355.PubMedCrossRefGoogle Scholar
  37. 37.
    Wynn AG, Gharib H, Scheithauer BW, et al. Hyperthyroidism due to inappropriate secretion of thyrotropin in 10 patients. Am J Med. 1992; 92: 15–24.CrossRefGoogle Scholar
  38. 38.
    Bartalena L, Grasso L, Brogioni S, et al. Serum interleukin6 in amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab. 1994; 78: 423–427.PubMedCrossRefGoogle Scholar
  39. 39.
    Solomon B, Glinoer D, Lagasse R, et al. Current trends in the management of Graves’ disease. J Clin Endocrinol Metab. 1990; 70: 1518–1524.PubMedCrossRefGoogle Scholar
  40. 40.
    Cooper DS, Goldminz D, Levin AA, et al. Agranulocytosis associated with antithyroid drugs: effects of patient age and drug dose. Ann Intern Med. 1983; 98: 26–29.PubMedGoogle Scholar
  41. 41.
    Geffner DL, Hershman JM. Beta-adrenergic blockade for the treatment of hyperthyroidism. Am J Med. 1992; 93: 61–68.PubMedCrossRefGoogle Scholar
  42. 42.
    Nakazawa HK, Sakurai K, Hamada N, et al. Management of atrial fibrillation in the post-thyrotoxic state. Am J Med. 1982; 72: 903–906.PubMedCrossRefGoogle Scholar
  43. 43.
    Kellett HA, Sawers JSA, Boulton FE, et al. Problems of anticoagulation with warfarin in hyperthyroidism. Q J Med. 1986; 58: 43–51.PubMedGoogle Scholar
  44. 44.
    Nicoloff JT. Thyroid storm and myxedema coma. Med Clin North Am. 1985; 69: 1005–1117.PubMedGoogle Scholar
  45. 45.
    Tenerz A, Forberg R, Jansson R. Is a more active attitude warranted in patients with subclinical thyrotoxicosis? J Intern Med. 1990; 228: 229–233.PubMedCrossRefGoogle Scholar
  46. 46.
    Mudde AH, Houben AJHM, Nieuwenhuijzen Kruseman AC. Bone metabolism during anti-thyroid drug treatment of endogenous subclinical hyperthyroidism. Clin Endocrinol. 1994; 41: 421–424.CrossRefGoogle Scholar
  47. 47.
    Utiger R. Subclinical hyperthyroidism just a low serum thyrotropin concentration, or something more? N Engl J Med. 1994; 331: 1302–1303.PubMedCrossRefGoogle Scholar
  48. 48.
    Davis PJ, Davis FM. Hypothyroidism in the elderly. Compr Ther. 1984; 10: 17–23.PubMedGoogle Scholar
  49. 49.
    Sawin CT, Chopra D, Azizi F, et al. The aging thyroid: increased prevalence of elevated serum thyrotropin levels in the elderly. JAMA. 1979; 242: 247–250.PubMedCrossRefGoogle Scholar
  50. 50.
    Mariotti S, Sansoni P, Barbesino G, et al. Thyroid and other organ-specific autoantibodies in healthy centenarians. Lancet. 1992; 339: 1506–1508.PubMedCrossRefGoogle Scholar
  51. 51.
    Sawin CT, Bigos ST, Land S, et al. The again thyroid: relationship between elevated serum thyrotropin level and thyroid antibodies in elderly patients. Am J Med. 1985; 79: 591–595.PubMedCrossRefGoogle Scholar
  52. 52.
    Martino E, Safran M, Aghini-Lombardi F, et al. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med. 1984; 101: 28–34.PubMedGoogle Scholar
  53. 53.
    Robuschi G, Safran M, Braverman LE, et al. Hypothyroidism in the elderly. Endocr Rev. 1987; 8: 142–152.PubMedCrossRefGoogle Scholar
  54. 54.
    Osterweil D, Syndulko K, Cohen SN, et al. Cognitive function in non-demented older adults and hypothyroidism. J Am Geriatr Soc. 1992; 40: 325–335.PubMedGoogle Scholar
  55. 55.
    Breteler M, Van Duijn C, Chandra V, et al. Medical history and the risk of Alzheimer’s disease: a collaborative reanalysis of case-control studies. Int J Epidemiol. 1991; 20 (suppl 2): S36 - S42.PubMedCrossRefGoogle Scholar
  56. 56.
    Docter R, Krenning EP, de Jong M, et al. The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol. 1993; 39: 499–518.CrossRefGoogle Scholar
  57. 57.
    Hays MT, Nielsen KRK. Human thyroxine absorption: age effects and methodological analyses. Thyroid. 1994; 4: 55–58.PubMedCrossRefGoogle Scholar
  58. 58.
    Carr D, McLeod DT, Parry G, et al. Fine adjustment of thyroxine replacement dosage: comparison of the thyrotrophin releasing hormone test using a sensitive thyrotrophin assay with measurement of free thyroid hormones and clinical assessment. Clin Endocrinol. 1988; 28: 325–333.CrossRefGoogle Scholar
  59. 59.
    Sawin CT, Herman T, Molitch ME, et al. Aging and the thyroid. Decreased requirement for thyroid hormone in older hypothyroid patients. Am J Med. 1983; 75: 206–209.PubMedCrossRefGoogle Scholar
  60. 60.
    Cunningham JJ, Barzel US. Lean body mass as a predictor of the daily requirement for thyroid hormone in older men and women. J Am Geriatr Soc. 1984; 32: 204–207.PubMedGoogle Scholar
  61. 61.
    Biondi B, Fazio S, Cerella C, et al. Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine. J Clin Endocrinol Metab. 1993; 77: 334–337.PubMedCrossRefGoogle Scholar
  62. 62.
    Stall GM, Harris S, Sokoll LJ, Dawson-Hughes B. Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine. Ann Intern Med. 1990; 113: 265–269.PubMedGoogle Scholar
  63. 63.
    Hay ID, Duick DS, Vlietstra RE, et al. Thyroxine therapy in hypothyroid patients undergoing coronary revascularization: a retrospective analysis. Ann Intern Med. 1981; 95: 456–457.PubMedGoogle Scholar
  64. 64.
    Ladenson PW, Levin AA, Ridgway EC, et al. Complications of surgery in hypothyroid patients. Am J Med. 1984; 77: 261–266.PubMedCrossRefGoogle Scholar
  65. 65.
    Surks M, Chopra IJ, Mariash CN, et al. American Thyroid Association guidelines for use of laboratory tests in thyroid disorders. JAMA. 1990; 263: 1529–1532.PubMedCrossRefGoogle Scholar
  66. 66.
    Cooper DS, Halpern R, Wood LC, et al. L-thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. Ann Intern Med. 1984; 101: 18–24.PubMedGoogle Scholar
  67. 67.
    Nystrom E, Caidahl K, Fager G, Wikkelso C, Lundberg PA, Lindstedt G. A double-blind cross-over 12-month study of L-thyroxine treatment of women with “subclinical” hypothyroidism. Clin Endocrinol. 1988; 29: 63–67.CrossRefGoogle Scholar
  68. 68.
    Monzani F, Del Guerra P, Caraccio N, et al. Subclinical hypothyroidism: neurobehavioral features and beneficial effect of L-thyroxine treatment. Clin Invest. 1993; 71: 367–371.Google Scholar
  69. 69.
    Arem R, Patsch W. Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Arch Intern Med. 1990; 150: 2097–2100.PubMedCrossRefGoogle Scholar
  70. 70.
    Rosenthal MJ, Hunt WC, Garry PJ, et al. Thyroid failure in the elderly: microsomal antibodies as discriminant for therapy. JAMA 1987; 258: 209–213.PubMedCrossRefGoogle Scholar
  71. 71.
    Nicoloff JT, LoPresti JS. Myxedema coma: a form of decompensated hypothyroidism. Endocrinol Metab Clin North Am. 1993; 22: 279–290.PubMedGoogle Scholar
  72. 72.
    Brander A, Viikinkoski P, Nickels J, et al. Thyroid gland: US screening in a random adult population. Radiology 1991; 181: 683–687.PubMedGoogle Scholar
  73. 73.
    Vander JB, Gaston EA, Dawber TR. The significance of nontoxic thyroid nodules. Ann Intern Med. 1968; 69: 537–540.PubMedGoogle Scholar
  74. 74.
    Belfiore A, La Rosa GL, La Porta GA, et al. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med. 1992; 93: 363–369.PubMedCrossRefGoogle Scholar
  75. 75.
    Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med. 1993; 328: 553–559.PubMedCrossRefGoogle Scholar
  76. 76.
    Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med. 1993; 118: 282–289.PubMedGoogle Scholar
  77. 77.
    Gharib H, Goellner JR, Zinsmeister AR. Fine-needle aspiration biopsy of the thyroid: the problem of suspicious cytologic findings. Ann Intern Med. 1984; 101: 25–28.PubMedGoogle Scholar
  78. 78.
    Gharib H, James EM, Charboneau JW, et al. Suppressive therapy with levothyroxine for solitary thyroid nodules. N Engl J Med. 1987; 317: 70–75.PubMedCrossRefGoogle Scholar
  79. 79.
    Reverter JL, Lucas A, Salinas I, et al. Suppressive therapy with levothyroxine for solitary thyroid nodules. Clin Endocrinol. 1992; 36: 25–28.CrossRefGoogle Scholar
  80. 80.
    Berghout A, Wiersinga WM, Drexhage HA, et al. Comparison of placebo with L-thyroxine alone or with carbimazole for treatment of sporadic non-toxic goitre. Lancet. 1990; 336: 193–197.PubMedCrossRefGoogle Scholar
  81. 81.
    Mandel SJ, Brent GA, Larsen PR. Levothyroxine therapy in patients with thyroid diseases. Ann Intern Med. 1993; 119: 492–502.PubMedGoogle Scholar
  82. 82.
    Cooper DS. Thyroxine suppression therapy for benign nodular disease. J Clin Endocrinol Metab. 1995; 80: 331–334.PubMedCrossRefGoogle Scholar
  83. 83.
    Schneider DL, Barrett-Connor EL, Morton DJ. Thyroid hormone use and bone mineral density in elderly women. JAMA. 1994; 271: 1245–1249.PubMedCrossRefGoogle Scholar
  84. 84.
    Huysmans DAKC, Hermus ARMM, Corstens FHM, Barentsz JO, Kloppenborg PWC. Large, compressive goiters treated with radioiodine. Ann Intern Med. 1994; 121: 757–762.PubMedGoogle Scholar
  85. 85.
    Hamberger JI. The presentation of thyroid malignancy in the geriatric patient. Henry Ford Hosp Med J. 1980; 28: 158–160.Google Scholar
  86. 86.
    Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994; 97: 418–428.PubMedCrossRefGoogle Scholar
  87. 87.
    Dulgeroff AJ, Hershman JM. Medical therapy for differentiated thyroid carcinoma. Endocr Rev. 1994; 15: 500–515.PubMedGoogle Scholar
  88. 88.
    Raue F, Frank-Raue K, Grauer A. Multiple endocrine neoplasia type 2: clinical features and screening. Endocrinol Metab Clin North Am. 1994; 23: 137–156.PubMedGoogle Scholar
  89. 89.
    Matsuzuka F, Miyauchi A, Katayama S, et al. Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 199 cases. Thyroid 1993; 93–99.Google Scholar
  90. 90.
    Nei CJC, van Heerden JA, Goellner JR, et al. Anaplastic carcinoma of the thyroid: a clinopathologic study of 82 cases. Mayo Clin Proc. 1986; 60: 51–58.Google Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • David S. Cooper

There are no affiliations available

Personalised recommendations